aalto1 untyped-item.component.html
Recent Updates on Viral Oncogenesis Available Preventive and Therapeutic Entities
Loading...
Access rights
openAccess
publishedVersion
URL
Journal Title
Journal ISSN
Volume Title
A2 Katsausartikkeli tieteellisessä aikakauslehdessä
This publication is imported from Aalto University research portal.
View publication in the Research portal (opens in new window)
View/Open full text file from the Research portal (opens in new window)
View publication in the Research portal (opens in new window)
View/Open full text file from the Research portal (opens in new window)
Unless otherwise stated, all rights belong to the author. You may download, display and print this publication for Your own personal use. Commercial use is prohibited.
Date
Department
Major/Subject
Mcode
Degree programme
Language
en
Pages
Series
Molecular Pharmaceutics, Volume 20, issue 8, pp. 3698–3740
Abstract
Human viral oncogenesis is a complex phenomenon and a major contributor to the global cancer burden. Several recent findings revealed cellular and molecular pathways that promote the development and initiation of malignancy when viruses cause an infection. Even, antiviral treatment has become an approach to eliminate the viral infections and prevent the activation of oncogenesis. Therefore, for a better understanding, the molecular pathogenesis of various oncogenic viruses like, hepatitis virus, human immunodeficiency viral (HIV), human papillomavirus (HPV), herpes simplex virus (HSV), and Epstein-Barr virus (EBV), could be explored, especially, to expand many potent antivirals that may escalate the apoptosis of infected malignant cells while sparing normal and healthy ones. Moreover, contemporary therapies, such as engineered antibodies antiviral agents targeting signaling pathways and cell biomarkers, could inhibit viral oncogenesis. This review elaborates the recent advancements in both natural and synthetic antivirals to control viral oncogenesis. The study also highlights the challenges and future perspectives of using antivirals in viral oncogenesis.
Description
Funding Information: Any organizations for this work supported no funding. Publisher Copyright: © 2023 The Authors. Published by American Chemical Society
Other note
Citation
Chowdhary, S, Deka, R, Panda, K, Kumar, R, Solomon, A D, Das, J, Kanoujiya, S, Gupta, A K, Sinha, S, Ruokolainen, J, Kesari, K K & Gupta, P K 2023, 'Recent Updates on Viral Oncogenesis Available Preventive and Therapeutic Entities', Molecular Pharmaceutics, vol. 20, no. 8, pp. 3698–3740. https://doi.org/10.1021/acs.molpharmaceut.2c01080